Location: Home > Pharma China Web Edition
  • search
  • go
  • News in Focus
  • 4/29/2026China Partnerships Drive Biopharma Deal Surge to $79B in Q1 2026
  • 4/28/2026China Imposes Four-Year Deadline on Conditionally Approved Drugs, Tigh...
  • 4/27/2026China Biopharma Financing Rebounds in March as AI Startups and Mega-De...
  • 4/22/2026China Biopharma Deal Activity Slows in Q1 2026, but Upfront Payments S...
  • 4/22/2026China's Push to Elevate Private Health Insurance Faces Structural Hurd...
  • 4/21/2026Chinese Biotech Commands One-Third of Global Pharma Deal Value in 16-M...
  • 4/16/2026China Deepens Opening of Biotech and Healthcare Sectors to Attract Glo...
  • 4/15/2026China Private Biotech Funding Slows in Deal Count but Reaches US$2 Bil...
  • 4/14/2026PhRMA Warns U.S. Drug Pricing Policies Could Accelerate China's Rise i...
  • 4/13/2026China Outbound Biopharma Licensing Surges as Global Demand for Innovat...
  • 4/9/2026China Backs Independent Pricing for Innovative Drugs in Landmark State...
  • 4/9/2026China's Innovative Drug Out-Licensing Surge Tops CNY 400B in Q1 as Gl...
  • 4/7/2026China NMPA Clears 17 Novel Drugs in First Quarter, Highlighting Sustai...
  • 4/1/2026Biotech VCs Move Upstream in China as Competition for Innovation Inten...
  • 3/25/2026IQVIA Report Highlights Rising Use and Intensifying Competition in Chi...
  • 3/24/2026Global Pharma Ramps Up China Investment as 15th Five-Year Plan Priorit...
  • 3/17/2026US Reshoring Push Clouds Long-Term Outlook for China's Contract Drugma...
  • 3/12/2026China's Labs Race for the Next First-in-Class Breakthrough
  • 3/10/2026China Biotech Dealmaking Defies Seasonal Slowdown as February Licensin...
  • 3/9/2026China Biotech Financing Rebounds in Early 2026 as RNA Deals and Global...
  • 3/4/2026China Biotech Outlicensing Surges Past US$52 Billion in Early 2026
  • 2/25/2026China Outpaces US and EU in Drug R&D with Faster Trials and Lower Cost...
  • 2/25/2026Global Pharma Giants Rush to License Chinese Weight-Loss Drugs, Eye Ob...
  • 2/20/2026China Biotech Kicks Off 2026 with $863 Million in January Raises
  • 2/13/2026China Biotech Dealmaking and Financing Stay Strong in January 2026 Des...
  • 2/12/2026China NMPA Approves Nine New Drugs in January 2026, Expanding Beyond O...
  • 2/10/2026China Overhauls Drug Administration Rules, Emphasizing Quality and Cli...
  • 2/5/2026China Biotech Emerges as Global Deal Powerhouse, Analysts Cite Strong ...
  • 1/27/2026China's Early-Stage Drug Advantage Seen Persisting: Pitchbook
  • 1/23/2026China's Commercial Health Insurance Payouts for Innovative Drugs and D...
  • Page:1/3 Total number of articles:79: [First][<<] [1] [2] [3] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group